On the other hand a study with 31 LGGs by Leu et al. did not find any significant difference between IDH-WT, IDH-Mutant/1p19q+ and IDH-mutant/1p19q− gliomas using ADC or rCBVleu [39]. The gene discussed is IDH1; the disease is central nervous system cancer.